List of insiders holdings for Karyopharm Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Chione Ltd Czernik Marcin Hadjimichael Andreas Hadjimichael Amalia Smolokowski Wiaczeslaw 10% Owner | 2023-02-14 15:41:13 | 4,400,000 0 | 4,400,000 | Form 13G |
| Chione Ltd Czernik Marcin Hadjimichael Andreas Hadjimichael George Smolokowski Wiaczeslaw 10% Owner | 2023-02-14 15:41:13 | 4,400,000 0 | 4,400,000 | Form 13G |
| Shacham Sharon Chief Scientific Officer | 2022-03-31 16:17:01 | 1,048,131 713,757 | 1,761,888 | Form 4 |
| Kauffman Michael Director | 2022-03-02 15:18:21 | 740,757 898,131 | 1,638,888 | Form 4 |
| Plio Ltd Czernik Marcin Hadjimichael Andreas Hadjimichael Amalia Jankilevitsch Gregory Former 10% Owner (exit filing) 10% Owner | 2016-02-22 19:07:49 | 1,200,203 0 | 1,200,203 | Form 13G |
| Paulson Richard A. President and CEO | 2024-12-05 16:15:34 | 1,128,312 0 | 1,128,312 | Form 4 |
| Cheng Sohanya Roshan EVP & Chief Commercial Officer | 2024-09-05 16:13:48 | 404,051 0 | 404,051 | Form 4 |
| Mason Michael EVP, CFO & Treasurer | 2024-09-05 16:24:30 | 391,054 0 | 391,054 | Form 4 |
| Rangwala Reshma EVP & Chief Medical Officer | 2024-04-23 16:02:01 | 342,931 0 | 342,931 | Form 4 |
| Poulton Stuart EVP, Chief Development Officer | 2024-07-31 16:14:51 | 326,628 0 | 326,628 | Form 4 |
| Mano Michael SVP, General Counsel&Secretary | 2024-09-05 16:28:14 | 273,881 0 | 273,881 | Form 4 |
| Frenkel Ran EVP, Chief Dev. Officer | 2022-03-02 15:34:13 | 258,290 0 | 258,290 | Form 4 |
| Varadan Anand EVP, Chief Commercial Officer | 2019-02-19 16:30:54 | 141,500 0 | 141,500 | Form 4 |
| Abate Kristin Chief Accounting Officer | 2024-11-22 16:01:57 | 140,300 0 | 140,300 | Form 3 |
| Shah Jatin EVP, Chief Medical Officer | 2022-02-22 16:19:03 | 129,450 0 | 129,450 | Form 4 |
| Mitchener Stephen SVP, Chief Business Officer | 2023-03-02 17:36:32 | 128,313 0 | 128,313 | Form 4 |
| Lewis Tanya EVP, Chief Reg. Affairs | 2021-03-01 20:13:00 | 105,369 0 | 105,369 | Form 4 |
| Renz Justin A EVP, CFO & Treasurer | 2017-01-24 17:36:39 | 100,000 0 | 100,000 | Form 4 |
| FALVEY MICHAEL EVP, CFO & Treasurer | 2018-01-25 16:30:49 | 95,000 0 | 95,000 | Form 4 |
| Todisco Michael VP, Finance & Assistant Treas | 2017-04-10 16:09:20 | 70,000 0 | 70,000 | Form 3 |
| Schor Chen Director | 2024-05-30 17:32:35 | 69,000 0 | 69,000 | Form 4 |
| BOHLIN GAREN G Director | 2024-05-30 17:19:59 | 69,000 0 | 69,000 | Form 4 |
| Greene Barry E Director | 2024-05-30 17:25:11 | 69,000 0 | 69,000 | Form 4 |
| Mirza Mansoor Raza Director | 2024-05-30 17:32:34 | 69,000 0 | 69,000 | Form 4 |
| Oliger Christy J. Director | 2024-05-30 17:32:34 | 69,000 0 | 69,000 | Form 4 |
| Primiano Christopher Brett EVP, CBO, GC & Secretary | 2020-12-03 17:17:14 | 68,241 0 | 68,241 | Form 4 |
| DEMAREE JOHN Chief Commercial Officer | 2021-03-01 20:10:55 | 67,172 0 | 67,172 | Form 4 |
| Brannelly Paul SVP, FINANCE & ADMIN, TREAS | 2014-05-15 16:42:10 | 66,136 0 | 66,136 | Form 4 |
| Su Zhen Director | 2024-05-30 17:32:37 | 50,587 0 | 50,587 | Form 4 |
| Honig Peter Director | 2023-05-25 16:06:10 | 34,000 0 | 34,000 | Form 4 |
| Thiel Carsten Director | 2018-09-04 16:38:34 | 34,000 0 | 34,000 | Form 4 |
| Peters Cameron VP of Finance | 2019-02-19 16:32:45 | 25,500 0 | 25,500 | Form 4 |
| Garland J. Scott Director | 2019-06-07 08:55:50 | 25,000 0 | 25,000 | Form 4 |
| Dolsten Mikael Director | 2021-05-21 17:32:53 | 23,900 0 | 23,900 | Form 4 |
| WEG KENNETH E Director | 2017-06-16 16:52:31 | 17,000 0 | 17,000 | Form 4 |
| PAKIANATHAN DEEPIKA Director | 2024-06-07 19:18:17 | 0 0 | 0 | Form 4 |